Recent Updates
Recently added Catalysts
IDYA

IDEAYA Announces Investor Day Webcast to Review Clinical Data from Phase 1 2 Trial of Darovasertib IDE196 Monotherapy and Combination with Binimetinib in Metastatic Uveal Melanoma

Thursday, April 15, 2021 1 min read
Key Takeaway: IDEAYA Announces Investor Day Webcast to Review Clinical Data from Phase 1 2 Trial of Darovasertib IDE196 Monotherapy and Combination with Binimetinib in Metastatic Uveal Melanoma

Full Press Release Details

IDEAYA Announces Investor Day Webcast to Review Clinical Data from Phase 1 2 Trial of Darovasertib IDE196 Monotherapy and Combination with Binimetinib in Metastatic Uveal Melanoma.
Tags: IDYA Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Apr 15, 2021